8,130
Views
3
CrossRef citations to date
0
Altmetric
Review

Treatment of carbapenem-resistant Pseudomonas aeruginosa infections: a case for cefiderocol

, &
Pages 1077-1094 | Received 17 Jan 2022, Accepted 26 Apr 2022, Published online: 10 May 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Emanuele Rando, Francesca Giovannenze, Rita Murri & Emilio Sacco. (2022) A review of recent advances in the treatment of adults with complicated urinary tract infection. Expert Review of Clinical Pharmacology 15:9, pages 1053-1066.
Read now

Articles from other publishers (2)

Carmen de la Fuente, Marina Rodriguez, Noemi Merino, Purificación Carmona, Isabel Machuca, María Córdoba-Fernández, J Guzmán-Puche, Arantxa Dominguez, Teresa-López Viñau, Lucrecia García, Jose Manuel Vaquero, Juan Carlos Robles, Luis Martínez-Martínez & Julian Torre-Cisneros. (2023) Real-life use of cefiderocol for salvage therapy of severe infections due to carbapenem-resistant Gram-negative bacteria. International Journal of Antimicrobial Agents, pages 106818.
Crossref
Carla López-Causapé, Ainhize Maruri-Aransolo, María A. Gomis-Font, Iván Penev, María García Castillo, Xavier Mulet, Juan de Dios Caballero, Rosa del Campo, Rafael Cantón & Antonio Oliver. (2023) Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients. Clinical Microbiology and Infection 29:4, pages 538.e7-538.e13.
Crossref